PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
19820032-13	2009	CONCLUSIONS: Loss-of-function mutations in FGFR1 underlie 7% of nIHH with different degrees of impairment in vitro.	nihh	64-68	fibroblast growth factor receptor 1	Homo sapiens	43-48
32485746-2	2021	FGFR1 mutations have been identified in 3-10% of patients with KS or nIHH.	nihh	69-73	fibroblast growth factor receptor 1	Homo sapiens	0-5
25180599-8	2014	A three-nucleotide in frame deletion was identified in the NPVF gene (p.I71_K72), with a smaller proportion in the CPP (5%) compared to the nIHH (15%) group (P = 0.06).	nihh	140-144	neuropeptide VF precursor	Homo sapiens	59-63
33299522-3	2020	FGFR1 variants are found in less than 10% of patients with KS and nIHH, and among them, only some have undergone functional analysis.	nihh	66-70	fibroblast growth factor receptor 1	Homo sapiens	0-5
24476074-4	2014	The coding region of AXL was sequenced in 104 unrelated, carefully phenotyped KS or nIHH subjects.	nihh	84-88	AXL receptor tyrosine kinase	Mus musculus	21-24
17959774-7	2007	Two brothers with KS and their sister with nIHH harbored a homozygous deletion in the PROK2 gene (p.[I55fsX1]+[I55fsX1]).	nihh	43-47	prokineticin 2	Mus musculus	86-91
17959774-11	2007	Homozygous loss-of-function PROK2 mutations cause both KS and nIHH.	nihh	62-66	prokineticin 2	Mus musculus	28-33